Tag Archives: Leukemia

Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate to Enter Preclinical Development in Acute Leukemia and Other Hematological Cancers

Barcelona, Spain (PRWEB) May 24, 2012 Oryzon announced today that it is entering preclinical development with its second drug candidate, a first-in-class specific Lysine Specific Demethylase 1 (LSD1) inhibitor for the treatment of hematological cancers. Our LSD1 inhibitors reduced tumor … Continue reading

Posted in Mao | Tagged , , , , , , , , , , , , , , | Leave a comment

Oryzon and Cancer Research UKS Paterson Institute for Cancer Research have Started a Collaborative Research Project on Therapeutic LSD1 Inhibitors for Acute Leukemia

Barcelona (PRWEB) September 10, 2012 Oryzon announces that Oryzon and Cancer Research UKs Paterson Institute for Cancer Research have entered into a collaboration to further study the potential of highly potent and highly-selective Oryzon LSD1 inhibitors in the treatment of … Continue reading

Posted in Mao | Tagged , , , , , , , , , , , , , | Leave a comment

Volunteers are the Life-Blood of The Leukemia & Lymphoma Societys Team In Training

San Francisco, CA (PRWEB) April 20, 2012 In honor of National Volunteer Appreciation Week (April 15-21), The Leukemia & Lymphoma Societys (LLS) Team In Training (TNT) is taking the time to thank its dedicated volunteers and recognize the top fundraisers … Continue reading

Posted in 40 Days For Life | Tagged , , , , , , | Leave a comment